БИОМАРКЕРЫ В ДИАГНОСТИКЕ И ПРОГНОЗЕ ПРИ ОСТРОМ КОРОНАРНОМ СИНДРОМЕ
Аннотация
Обзор обобщает современные представления диагностики и прогнозирования острого коронарного синдрома. Оценивает значимость каждого из диагностических тестов, чувствительных к повреждению миокарда и специфичных для ткани миокарда.
Об авторах
Л. Н. Верижникова
Сургутский государственный университет
Россия
Россия
Л. В. Коваленко
Сургутский государственный университет
Россия
Россия
И. А. Урванцева
Сургутский государственный университет
Россия
Россия
Список литературы
1. Goodacre S., Knockaert D. C., Buntinx F., Stoens N., Bruyninckx R. et al. The health care burden of acute chest pain. Chest pain in the emergency department: the broad spectrum of causes // Eur J Emerg Med. 2002. № 9. Р. 25-30 ; Heart. 2005. № 91. Р. 229-230.
2. Ekelund U., Nilsson H.-J., Frigyesi A., Torffvit O. Patients with suspected acute coronary syndrome in a university hospital emergency department: an observational study // BMC Emerg Med. 2002. № 2, 1 ; Goodacre S. W. et al. The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department // Heart. 2011. № 97. Р. 190-196.
3. Pasquale P., di et al. Sensitivity, specificity and predictive value of the echocardiography and troponin-T test combination in patients with non-ST elevation acute coronary syndromes // Int J Cardiovasc Imaging. 2004. № 20. Р. 37-46.
4. Schaub N., Reichlin T., Twerenbold R., Reiter M., Steuer S., Bassetti S. et al. Growth differentiation factor-15 in the early diagnosis and risk stratification of patients with acute chest pain // Clin Chem. 2012. № 58 (441). Р. 9.
5. Solinas L. et al. Prevalence, clinical characteristics, resource utilization and outcome of patients with acute chest pain in the emergency department. A multicenter, prospective, observational study in northeastern Italy // Ital Heart J. 2003. № 4. Р. 318-324 ; Pope J. H. et al. Missed diagnoses of acute cardiac ischemia in the emergency department // N Engl J Med. 2000. № 342. Р. 1163-1170.
6. Ferraro S., Marano G., Biganzoli Elia M., Boracchi P., Bongo Angelo S. Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target // Clin Chem Lab Med. 2011. № 49. (1397). Р. 404.
7. Thygesen K., Alpert J. S., Jaffe A. S., Simoons M. L., Chaitman B. R., White H. D. et al. Third universal definition of myocardial infarction // Eur Heart J. 2012 № 33 (2551). Р. 67.
8. Fong S. W., Few L. L., See Too W. C., Khoo B. Y., Nik Ibrahim N. N., Yahaya S. A., Yusof Z., Mohd Ali R., Abdul Rahman A. R., Yvonne-Tee G. B. Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease // BMC Res Notes. 2015. Nov. № 14 (80). Р. 679.
9. Nilsen D. W., Mjelva Ø. R., Leon de la Fuente R. A., Naesgaard P., Pönitz V., Brügger-Andersen T., Grundt H., Staines H., Nilsen S.T. Borderline Values of Troponin-T and High Sensitivity C-Reactive Protein Did Not predict 2-Year Mortality in TnT Positive Chest-Pain Patients, Whereas Brain Natriuretic Peptide Did. Front // Cardiovasc Med. 2015. Apr. 8. № 2. Р. 16.
10. Adams J., Abendschein D. R., Jaffe A. S. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? // Circulation. 1993. № 88 (750). Р. 63.
11. Wiviott S. D., Cannon C. P., Morrow D. A., Murphy S. A. et al. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy // Circulation. 2004. Feb. 10, № 109 (5). Р. 580.
12. Bosch X., Marrugat J., Sanchis J. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes // Cochrane Database Syst Rev. 2013. Nov. 8. 11:CD002130. doi: 10.1002/14651858. CD002130. рub 4.
13. Centurión O. A. Serum biomarkers and source of inflammation in acute coronary syndromes and percutaneous coronary interventions // Cardiovasc Revasc Med. 2016. Mar. 17. № 2 (119). Р. 28.
14. Collinson P. O., Gaze D. C., Thokala P., Goodacre S. Randomised Assessment of Treatment using Panel Assay of Cardiac markers-Contemporary Biomarker Evaluation (RATPAC CBE) // Health Technol Assess. 2013. № 17 (15). Р. 1-122.
15. Lin S., Yokoyama H., Rac V. E., Brooks S. C. Novel biomarkers in diagnosing cardiac ischemia in the emergency department: a systematic review // Resuscitation. 2012. № 83 (684). Р. 91.
16. Apple F. S., Smith S. W., Pearce L. A., Murakami M. M. Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome // Clin Chem. 2009. № 55 (93). Р. 100.
17. Lindahl B. Acute coronary syndrome - the present and future role of biomarkers // Clin Chem Lab Med. 2013. Sep. № 51(9):1699. Р. 706.
18. Santopinto J. J., Fox K. A., Goldberg R. J., Budaj A., Piñero G., Avezum A. et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE) // Heart. 2003. № 89 (1003). Р. 8.
19. Harrison T., Longo D., Kasper D., Jameson J., Fauci A., Hauser S. et al. Harrison’s principles of internal medicine. New York : McGrawHill, 2012.
20. Henry J., McPherson R., Pincus M., Abraham N. Henry’s clinical diagnosis and management by laboratory methods. Philadelphia : Sanders Elsevier, 2007.
21. Antman E. M., Grudzien C., Mitchell R. N. et al. Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T // Am Heart J. 1997. № 133 (596). Р. 8.
22. Pfister R., Tan D., Thekkanal J., Hellmich M., Schneider C. A. NT-proBNP is associated with long-term outcome in a heterogeneous sample of cardiac inpatients // Eur J Intern Med 2007. № 18 (3):215. Р. 20.
23. Heidenreich P. A., Alloggiamento T., Melsop K., McDonald K. M., Go A. S., Hlatky M. A. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis // J Am Coll Cardiol. 2001. № 38 (478). Р. 85.
24. Lindahl B., Diderholm E., Lagerqvist B., Venge P., Wallentin L. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy // J Am Coll Cardiol. 2001. № 38 (979). Р. 86.
25. Niccoli G., Conte M., Marchitti S., Montone R. A., Fracassi F. et al. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation // Cardiovasc Revasc. Med. 2016. Feb 27. pii: S1553-8389(16)30049-5.
26. Thygesen K. et al. Third universal definition of myocardial infarction // Eur Heart J 2011. № 33. Р. 2551-2567.
27. Waltenberger J. Pathophysiological bases of unstable coronary syndrome // Herz. 2001. Apr. 26. № 1 (2). Р. 8.
28. Ihling C. Pathomorphology of coronary atherosclerosis // Herz. 1998. Mar. № 23 (2). Р. 69-77.
29. Baruch A., van Bruggen N., Kim J. B., Lehrer-Graiwer J. E. Anti-inflammatory strategies for plaque stabilization after acute coronary syndromes // Curr Atheroscler Rep. 2013. Jun № 15 (6). Р. 327.
30. Alkofide H., Huggins G. S, Beshansky J. R, Ruthazer R., Peter I. et al. C-Reactive protein reactions to glucose-insulin-potassium infusion and relations to infarct size in patients with acute coronary syndromes // BMC Cardiovasc Disord. 2015. Dec. 3 (15) Р. 163.
31. James S. K., Oldgren J., Lindbäck J., Johnston N., Siegbahn A., Wallentin L. An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease // Am Heart J. 2005. № 149 (619). Р. 26.
32. He L-P., Tang X-Y., Ling W-H., Chen W-Q., Chen Y-M. Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies // Heart. 2010. № 96 (339). Р. 46.
33. Lakkis N., Tsyboulev V., Gibson C. M., Murphy S. A., Weintraub W. S., DiBattiste P. M., Cannon C. P. TACTICS-TIMI-18 Investigators. Outcome of patients with acute coronary syndrome admitted to hospitals with or without onsite cardiac catheterization laboratory: a TACTICS-TIMI 18 substudy // Crit Pathw Cardiol. 2002. Dec. 1(4):232. Р. 7.
34. Correia L., Esteves J. C-reactive protein and outcomes in acute coronary syndromes: a systematic review and meta-analysis // Arq Bras Cardiol. 2011. № 97 (76). Р. 85.
35. James S. K., Armstrong P., Barnathan E., Califf R., Lindahl B., Siegbahn A. et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy // J Am Coll Cardiol. 2003. № 41 (916). Р. 24.
36. Apple F. S., Wu A. H., Mair J., Ravkilde J., Panteghini M., Tate J. et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome // Clin Chem. 2005. № 51 (810). Р. 24.
37. Fu X., Kassim S. Y., Parks W. C., Heinecke J. W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase // J Biol Chem. 2001. № 276 (41279). Р. 87.
38. Andre P., Nannizzi-Alaimo L., Prasad S. K., Phillips D. R. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease // Circulation. 2002. № 106 (896). Р. 9.
39. Iyer S., Acharya K. R. Role of placenta growth factor in cardiovascular health // Trends Cardiovasc Med. 2002. № 12 (128). Р. 34.
40. Heeschen C., Dimmeler S., Fichtlscherer S., Hamm C. W., Berger J., Simoons M. L., Zeiher A. M. Prognostic value of placental growth factor in patients with acute chest pain // JAMA. 2004. № 291 (435). Р. 41.
41. Heeschen C., Dimmeler S., Hamm C. W., van den Brand M. J., Boersma E., Zeiher A. M., Simoons M. L. Soluble CD40 ligand in acute coronary syndromes // N Engl J Med. 2003. № 348 (1104). Р. 11.
42. O'Gara P. T. et al. ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation /American Heart Association Task Force on Practice Guidelines // J Am Coll Cardiol. 2013. № 61. Р. 78-140.
43. Grabowski M., Filipiak K. J., Malek L. A., Karpinski G., Huczek Z., Stolarz P., Spiewak M., Kochman J., Rudowski R., Opolski G. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty // Int J Cardiol 2007. № 115(3):386. Р. 90.
44. Ndrepepa G., Braun S., Mehilli J., von Beckerath N., Schomig A., Kastrati A. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes // Eur J Clin Invest. 2008. № 38 (90). Р. 6.
45. Rognoni A., Cavallino C., Lupi A., Secco G. G., Veia A., Bacchini S., Rosso R., Rametta F., Bongo A. S. Novel biomarkers in the diagnosis of acute coronary syndromes: the role of circulating miRNAs // Expert Rev. Cardiovasc. Ther. 2014. Sep. № 12(9):1119. Р. 24.
46. Laterza O. F., Price C. P., Scott M. G. Cystatin C: an improved estimator of glomerular filtration rate? // Clin Chem. 2002. № 48 (699). Р. 707.
47. García Acuña J. M., González-Babarro E., Grigorian Shamagian L., Peña-Gil C., Vidal Pérez R., López-Lago A. M. et al. Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome // Rev Esp Cardiol. 2009. № 62 (510). Р. 9.
48. Kempf T., Eden M., Strelau J., Naguib M., Willenbockel C., Tongers J. et al. The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury // Circ Res. 2006. № 98 (351). Р. 60.
49. Sathyamurthy I., Dalal J. J., Sawhney J. P., Mohan J. C., Chogle S. A., Desai N., Sathe S. P., Maisel A. S. Cardiac Biomarkers for Better Management of Acute Coronary Syndromes // J Assoc Physicians India. 2015 Jun. № 63(6) Р. 46-50.
50. Eggers K. M., Kempf T., Venge P., Wallentin L., Wollert K. C., Lindahl B. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers // Am Heart J. 2010. № 16. Р. 88-94.
51. Wang F., Long G., Zhao C., Li H., Chaugai S., Wang Y., Chen C., Wang D. W. Atherosclerosis-related circulating miRNAs as novel and sensitive predictors for acute myocardial infarction // PLoS One. 2014. Sep. 3. № 9 (9). е105734.
52. Wang F. F., Chen B. X., Yu H. Y., Mi L., Li Z. J., Gao W. Correlation between growth differentiation factor-15 and collagen metabolism indicators in patients with myocardial infarction and heart failure // J Geriatr Cardiol. 2016. Jan. 13(1). Р. 88-93.
53. Meyer T., Herrmann-Lingen C., Chavanon M. L., Pieske B., Wachter R., Edelmann F. Plasma mid-regional pro-adrenomedullin levels are inversely associated with anxiety but unrelated to depression: Results from the observational DIAST-CHF study in patients with cardiovascular risk factors // Psychoneuroendocrinology. 2015. Dec. № 62 (227). Р. 32. ; Peacock W. F. Novel biomarkers in acute heart failure: MR-pro-adrenomedullin // Clin Chem Lab Med. 2014. Oct. № 52 (1433). Р. 5.
54. Matusik P., Guzik B., Weber C., Guzik T. J. Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice? // Thromb Haemost. 2012. Sep. № 108 (3) :443 Р. 56. doi: 10.1160/TH12-05-0341.
55. Morrow D. A, Cannon C. P, Rifai N., Frey M. J., Vicari R., Lakkis N. et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial // J Am Med Assoc. 2001. № 286 (2405). Р. 12.
56. Hamm C. W., Bassand J-P., Agewall S., Bax J., Boersma E., Bueno H. et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) // Eur Heart J. 2011. № 32 (2999). Р. 3054.
57. Wang X., Chen L. L., Zhang Q. Increased serum level of growth differentiation factor 15 (GDF-15) is associated with coronary artery disease // Cardiovasc Ther. 2016. Mar. 21. № 115 (962). Р. 71. doi: 10.1111/1755-5922.
58. Li C., Pei F., Zhu X., Duan D. D., Zeng C. Circulating microRNAs as novel and sensitive biomarkers of acute myocardial infarction // Clin Biochem. 2012. № 45 (727). Р. 32.
59. Pohlhammer J., Kronenberg F., Rantner B., Stadler M., Peric S., Hammerer-Lercher A. et al. High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality - The CAVASIC Study. // Atherosclerosis. 2014. № 237(2):711. Р. 7.
60. Goodacre S., Thokala P., Carroll C., Stevens J. W., Leaviss J., Al Khalaf M. et al. Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome // Health Technol Assess. 2013. № 17 (1).
61. Windhausen F., Hirsch A., Sanders G. T, Cornel J. P., Fischer J., van Straalen J. et al. N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy // Am Heart J. 2007. № 153 (485). Р. 92.
62. Andre P., Nannizzi-Alaimo L., Prasad S. K., Phillips D. R. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease // Circulation. 2002. № 106 (896). Р. 9.
Рецензия
Для цитирования:
Верижникова Л.Н., Коваленко Л.В., Урванцева И.А. БИОМАРКЕРЫ В ДИАГНОСТИКЕ И ПРОГНОЗЕ ПРИ ОСТРОМ КОРОНАРНОМ СИНДРОМЕ. Вестник СурГУ. Медицина. 2016;(2 (28)):6-12.
For citation:
Verizhnikova L.N., Kovalenko L.V., Urvantseva I.A. BIOMARKERS IN DIAGNOSTICS AND PROGNOSIS AT ACUTE CORONARY SYNDROME. Vestnik SurGU. Meditsina. 2016;(2 (28)):6-12. (In Russ.)
Просмотров:
170
Послать статью по эл. почте 
